Carlos Paz

Statistics

Publications

Citations

138

H-Index

Active since

2016

Affiliations

Wellcome Sanger Institute(Current)

Carlos Paz is an author at Wellcome Sanger Institute specializing in topoisomerase i inhibitors, medical microbiology, and tuberculosis drug development.

ORCID

Publications per year

2016–2020

Publications

Large-scale RNAi screening uncovers therapeutic targets in the parasite <i>Schistosoma mansoni</i>

Jipeng Wang, Carlos Paz, Gilda Padalino et al. · Science · 2020 · 96 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +12

Small-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents

Shayna Sandhaus, Thirunavukkarasu Annamalai, Greg Welmaker et al. · Antimicrobial Agents and Chemotherapy · 2016 · 42 citations · Full text

Pharmacy, Medicinal Chemistry, Microbiology +16

1–2 of 2